Pregnancy After a Breast Cancer Diagnosis
Study finds pausing endocrine therapy is safe for early-stage breast cancer patients eager to expand their families.
Progress Against Cancer
Study finds pausing endocrine therapy is safe for early-stage breast cancer patients eager to expand their families.
Black breast cancer patients had worse outcomes in a recent study, even when cancer features aligned with white patients.
AACR patient advocate forum addresses developments in cancer early detection tests.
Five years after the FDA approved the first CAR T-cell therapy, use of the treatment has expanded to many patients with blood cancer.
New studies probe how to match targeted therapies to children with cancer.
A magnet-guided robot could help doctors look for signs of cancer deeper in the passages of the lungs.
Study shows women have a higher risk of side effects from immunotherapy, adding to evidence that men and women react differently to treatment.
Genetic tests create opportunities but also confusion for breast cancer patients, and more from the week in cancer news.
Cognitive effects from COVID-19 and cancer treatment look very similar. Collaboration may lead to better treatment for both.
A new study adds nuance to the ‘golden age’ of cancer drug approvals.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More